» Articles » PMID: 16959438

Predictors of Non-fatal Overdose Among a Cohort of Polysubstance-using Injection Drug Users

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2006 Sep 9
PMID 16959438
Citations 138
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Non-fatal overdose is a major determinant of morbidity among injection drug users (IDU). We sought to evaluate factors associated with non-fatal overdose among IDU in Vancouver.

Methods: We examined non-fatal overdose among participants in the Vancouver Injection Drug Users Study. Correlates of non-fatal overdose occurring between 1996 and 2004 were identified using generalized estimating equations (GEE).

Results: There were 1587 participants included in this analysis, including 576 (36%) women. At baseline, 750 (47%) reported a history of non-fatal overdose. In total, 985 reports of non-fatal overdose were made during follow-up by 519 (32.7%) participants. In multivariate GEE analyses, factors independently associated with non-fatal overdose included: heroin injection (AOR=2.67), cocaine injection (AOR=2.01), benzodiazepine use (AOR=2.00), requiring help injecting (AOR=1.58), binge drug use (AOR=1.52), homelessness (AOR=1.38), alcohol use (AOR=1.32), street injecting (AOR=1.22), non-injectable opiate use (AOR=1.16), speedball use (AOR=1.15), and recent incarceration (AOR=1.14). Younger age (AOR=0.99) and methadone use (AOR=0.51) were protective.

Conclusions: We found that non-fatal overdose was common among local IDU. Non-fatal overdose was associated with several factors that may be amenable to intervention, including opiate and stimulant use, and the characteristic of requiring help with injecting. These findings indicate the need for the ongoing development of structural interventions to address this common cause of morbidity among IDU.

Citing Articles

Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction services.

Ziafat K, Liu L, Kievit B, Papamihali K, Graham B, Otterstatter M BMJ Open. 2025; 15(1):e090704.

PMID: 39819909 PMC: 11752018. DOI: 10.1136/bmjopen-2024-090704.


Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States.

Zang X, Skinner A, Li Z, Shaw L, Behrends C, Chatterjee A Addiction. 2024; 120(2):316-326.

PMID: 39450522 PMC: 11707306. DOI: 10.1111/add.16691.


Psychosocial factors associated with overdose subsequent to Illicit Drug use: a systematic review and narrative synthesis.

Byrne C, Sani F, Thain D, Fletcher E, Malaguti A Harm Reduct J. 2024; 21(1):81.

PMID: 38622647 PMC: 11017611. DOI: 10.1186/s12954-024-00999-8.


The relationship between felt stigma and non-fatal overdose among rural people who use drugs.

Sibley A, Klein E, Cooper H, Livingston 3rd M, Baker R, Walters S Harm Reduct J. 2024; 21(1):77.

PMID: 38582851 PMC: 10998326. DOI: 10.1186/s12954-024-00988-x.


Effects of a Two-Month Exercise Training Program on Concurrent Non-Opiate Substance Use in Opioid-Dependent Patients during Substitution Treatment.

Psarianos A, Chryssanthopoulos C, Theocharis A, Paparrigopoulos T, Philippou A J Clin Med. 2024; 13(4).

PMID: 38398255 PMC: 10888880. DOI: 10.3390/jcm13040941.